Blood cancer patients on Bruton’s tyrosine kinase inhibitors should continue at time of COVID-19 vaccination, study says

MyBlueDots5 hours ago01 mins

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 vaccinations, a new study suggests.

Go to Source
https://medicalxpress.com/rss-feed/

How controversial nutritionist John Harvey Kellogg pioneered the path to modern plant-based eating

MyBlueDots5 hours ago 0

A specialized diet with flavor improvement can improve gut disorders

MyBlueDots5 hours ago 0

Intravascular imaging can improve outcomes for complex stenting procedures in calcified coronary arteries

MyBlueDots5 hours ago 0

Experts concerned as NIH axes critical vaccine study funds

MyBlueDots5 hours ago 0

Top

Useful _Links

How controversial nutritionist John Harvey Kellogg pioneered the path to modern plant-based eating

A specialized diet with flavor improvement can improve gut disorders

Intravascular imaging can improve outcomes for complex stenting procedures in calcified coronary arteries

Experts concerned as NIH axes critical vaccine study funds

Detailed atlas identifies optimal viral vectors for precise gene therapy

Computational platform helps unlock A20’s dual role in cancer immunotherapy

Blood cancer patients on Bruton’s tyrosine kinase inhibitors should continue at time of COVID-19 vaccination, study says

World News

Useful Links

Health

Business

Entertainment

About Us

Useful Links

Related News

Useful _Links